Clinical Trials · NCT06959784
Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)
- Phase
- Phase 4
- Recruitment status
- Enrolling By Invitation
- Sponsor
- China-Japan Friendship Hospital
- Enrollment
- 142
- Start date
- Jan 2024
- Locations
- 1 site, China
- Primary endpoint
- Cardiovascular and cerebrovascular event risk score